Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery
Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery
Not yet recruiting · NCT07654296 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery | Multimodal Analgesia; Opioid Consumption, Postoperative; Ureteral Stent-Related Symptoms; Ureteral Stents; Ureteroscopy | Not yet recruiting | Phase 3 | 2026-09-18 | NCT07654296 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
| Vertex Pharmaceuticals Incorporated | 37 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Faulkner Hospital | Boston | United States | 8 |
| Brigham and Women's Hospital | Boston | United States | 511 |